Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
INJECTION
**【DOSAGE AND ADMINISTRATION】** Albumin SG Injection 20% 125–375mL, equivalent to human serum albumin 25–75g should be administered by intravenous drip infusion or by slow direct intravenous injection. The recommended infusion rate is 2–4mL/min. It may be diluted with 5% glucose and 0.9% sodium chloride when necessary. The dosage may be adjusted according to body weight, age and symptoms.
INTRAVENOUS
Medical Information
**【INDICATIONS】** Hypoalbuminemia caused by albumin loss (burn, nephrotic syndrome, etc), dysfunction of albumin synthesis (liver cirrhosis, etc) and haemorrhagic shock
**【CONTRAINDICATION】** Patients with history of hypersensitivity to this drug and its ingredients
B05AA01
albumin
Manufacturer Information
THE REG CONSULTANTS PTE. LTD.
SK Plasma Co.,Ltd.
Active Ingredients
Documents
Package Inserts
ALBUMIN SG PI.pdf
Approved: April 20, 2023